Share this post on:

Product Name :
PF-05089771

Search keywords :
PF 05089771

drugId :
null

Target Vo:
Sodium channel protein type IX alpha subunit

Target Vo Short Name :
SCN9A

Moa_Name:
Sodium channel protein type IX alpha subunit blockers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Medical University Of Vienna

Active Indication_Name:
Pain

In Active Indication_Name:
Erythromelalgia

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-HA tag Rabbit mAb supplier
AKT1 Rabbit mAb Autophagy
FEN1 Antibody (YA765): FEN1 Antibody (YA765) is a non-conjugated and Mouse origined monoclonal antibody about 43 kDa, targeting to FEN1 (1E7). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related